日本多中心研究:EVAR术后开放手术转换的指征与结局
日本13家血管中心回顾性分析2006至2024年EVAR术后行开放手术转换(OSC)的208例患者,主要指征为II型内漏伴瘤囊增大(47.1%)。总体30天死亡率为4.3%,破裂病例升至13.2%,破裂是30天死亡的独立危险因素(HR 5.93)。
要点
- II型内漏伴瘤囊增大是EVAR术后OSC最常见指征(47.1%)。
- 破裂患者30天死亡率显著升高(13.2% vs 非破裂2.4%)。
- 需优化择期OSC指征以避免破裂和治疗延迟。
核心结论
- II型内漏是日本EVAR术后OSC的主要指征,破裂显著增加30天死亡率。
研究设计与样本
- 日本13家血管中心回顾性队列研究,纳入2006至2024年EVAR术后行OSC的208例患者。
主要发现
- 中位年龄78岁,男性85.6%,中位AAA直径62 mm,EVAR至OSC中位间隔5.2年。
- OSC指征:II型内漏伴瘤囊增大47.1%,I型内漏23.1%,V型内漏伴瘤囊增大13.0%,感染10.1%,III型内漏9.6%。
- 总体30天死亡率4.3%,非破裂2.4%,破裂13.2%;破裂为30天死亡危险因素(HR 5.93,95%CI 1.59-22.1,P=.008)。
- 10年总生存率58.4%,动脉瘤相关死亡率14.8%,10年免于再治疗率87.5%。
关键数值与推荐
- 30天死亡率:总体4.3%,非破裂2.4%,破裂13.2%。
- 破裂与30天死亡风险比HR 5.93(95%CI 1.59-22.1,P=.008)。
- 10年总生存率58.4%,动脉瘤相关死亡率14.8%,免于再治疗率87.5%。
临床怎么用
- 对EVAR术后II型内漏伴瘤囊增大患者应积极评估择期OSC指征,避免破裂和治疗延迟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to evaluate indications and outcomes of open surgical conversion (OSC) after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm using a multicenter registry in Japan. METHODS: Thirteen vascular centers retrospectively reviewed patients who underwent OSC after prior EVAR between 2006 and 2024. Baseline characteristics, indications, procedural details, and outcomes were analyzed. The primary end point was 30-day mortality. Secondary end points were overall survival, aneurysm-related mortality, and freedom from retreatment. RESULTS: A total of 208 patients (85.6% males; median age, 78 years) were included. The median abdominal aortic aneurysm diameter was 62 mm. The median interval from initial EVAR to OSC was 5.2 years. Indications for OSC were type II endoleak with sac enlargement (47.1%), type I endoleak (23.1%), type V endoleak with sac enlargement (13.0%), infection (10.1%), and type III endoleak (9.6%). The most frequently used stent graft was the Excluder, followed by Endurant and Zenith. Complete stent graft removal was performed in 41 patients, partial removal in 51, and 116 underwent OSC with stent graft preservation. Thirty-eight patients (18.3%) presented with rupture and 48 (23.1%) underwent urgent OSC. The 30-day mortality rate was 4.3% in the overall cohort, 2.4% in nonruptured cases, and 13.2% in ruptured cases. Rupture was a risk factor for 30-day mortality (hazard ratio, 5.93; 95% confidence interval, 1.59-22.1; P = .008). At 10 years, overall survival and aneurysm-related mortality were 58.4% and 14.8%, respectively, and freedom from retreatment rate was 87.5% at 10 years. CONCLUSIONS: Type II endoleak was the leading common indication for OSC after EVAR in this multicenter retrospective study in Japan. Rupture at OSC markedly increased 30-day mortality, even in patients with type II endoleak. Further studies are needed to refine elective indications for OSC to prevent aneurysmal rupture and avoid treatment delay.
引用
- Morisaki K, Sano M, Miyake K, et al. Open surgical conversion after endovascular aneurysm repair in Japan: Indications and outcomes from a multicenter study (JAST-CONVERT). J Vasc Surg. 2026. PMID: 41544779. doi:10.1016/j.jvs.2026.01.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。